Ocular Therapeutix Inc (OCUL)

followers · Follow

Sector:	HEALTH CARE
Industry:	HEALTH CARE SUPPLIES
SIC:	PHARMACEUTICAL PREPARATIONS
CEO:	Antony Mattessich
Employees:	230
Web site:	ocutx.com
15 CROSBY DRIVE, BEDFORD, MA, 01730 781-357-4000

	All 13F Filers	Prior	Change	Hedge Funds ¹	Prior	Change

Ocular Therapeutix, Inc. focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery. It is also developing OTX-TKI, an axitinib intravitreal implant that is in phase 1 clinical trials for the treatment of wet age-related macular degeneration and other retinal diseases.

Please log in first to see chart

Ocular Therapeutix Inc YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Shareholders (13F, 13D/G)

Current Mutual Fund/ETF Holders

Active 13D/G Filings

SEC Filings

Insiders

Short Positions

Congress

Proposed Sales

Comments and Updates

To Excel | To CSV | To TSV

Investor	History	Shares Held or Principal Amt	Market Value	% of Portfolio	Previous % of Portfolio	Rank	Change in Shares	% Change in Shares	% Ownership	Qtr 1st Owned	Est. Avg Price	Source	Source Date	Date Reported
No data available